USPH

Business Context and Reporting Period

Company: U.S. Physical Therapy, Inc.
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: September 30, 2000
Business Overview: The Company operates 130 outpatient physical and occupational therapy clinics across 30 states, providing post-operative care and treatment for orthopedic and sports-related injuries. As of the reporting date, the average age of clinics was 3.79 years. The Company discontinued its surgery center initiative in March 2000 to focus exclusively on therapy clinic growth.

Key Financial Metrics

Note: Debt figures include $658k current notes payable, $1,509k long-term notes payable, and $8,050k convertible subordinated notes.

Material Changes vs. Prior Period

• Revenue Growth: Net revenues increased 22% ($2.8M) for the quarter and 23% ($8.5M) for the nine months compared to the prior year. Growth was driven by 25 new clinics (contributing 57% of Q3 growth) and a 10-15% increase in patient visits at existing clinics.
• Profitability: Net income rose 59% for the quarter and 53% for the nine months. Operating margins improved slightly as clinic operating costs as a percentage of revenue decreased from 72% to 71% (Q3) and 74% to 72% (9 months).
• Stock Repurchase: The Company repurchased 565,000 shares of common stock in August 2000 for $6.275 million. This significantly reduced cash reserves and increased the debt-to-equity ratio from 0.76 to 1.43.
• Cost Structure: Salaries and related costs increased 20% (Q3) and 18% (9 months), primarily due to new clinic openings and increased staffing. Recruitment costs decreased in Q3 due to the discontinuance of the surgery center initiative but increased for the nine months due to severance and development costs associated with that initiative.

Guidance, Outlook, and Risks

• Expansion Goals: The Company aims to open 30 new clinics in 2000. Five new facilities opened in October 2000, marking entry into the California market. Management expects new clinics to have lower initial margins due to start-up costs.
• Strategic Shift: The surgery center initiative was discontinued in March 2000. Costs associated with this discontinuance totaled $348,000 for the nine months ended September 30, 2000.
• Liquidity and Debt: Cash decreased by $1.6 million primarily due to the stock repurchase. The Company utilized a $2.115 million convertible line of credit to fund the repurchase. This line converts to a term loan on December 31, 2000, repayable in quarterly installments starting March 2001. A separate $500,000 revolving line of credit remains available for working capital.
• Regulatory Environment: The Company is subject to the Balanced Budget Act of 1997 and the Balanced Budget Refinement Act of 1999, which placed a two-year moratorium on the $1,500 Medicare reimbursement limit for therapy services in 2000 and 2001.
• Accounting Changes: The Company will adopt SFAS 133 (Derivatives) in fiscal year 2001 and SAB 101 (Revenue Recognition) in Q4 2000. Management does not expect these to have a material effect.

Investor Verification Checklist

• Debt Service Capacity: Verify the Company's ability to service the new $2.115 million term loan (quarterly payments starting March 2001) alongside existing convertible notes ($8.05 million principal).
• New Clinic Performance: Monitor the ramp-up period for the 25 new clinics opened in 2000 to ensure they meet projected revenue and margin targets.
• Medicare Reimbursement: Assess the impact of the expiration of the two-year moratorium on the $1,500 Medicare therapy cap in 2002.
• Stock Repurchase Impact: Evaluate the long-term benefit of the $6.3 million share buyback against the reduction in liquidity and increase in leverage.
• Minority Interest Dilution: Review the increasing minority interest in subsidiary limited partnerships ($2.64M for 9 months 2000 vs $1.87M in 1999), which reduces net income attributable to common shareholders.